Literature DB >> 27037271

Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections.

Friederike Quittnat Pelletier1, Mohammad Joarder2, Susan M Poutanen3, Charmaine E Lok4.   

Abstract

BACKGROUND AND OBJECTIVES: Guideline-recommended diagnostic criteria for hemodialysis (HD) catheter-related bloodstream infections (CRBSIs) are based on data from indwelling central catheters in patients not on HD and non-HD situations, and upon which peripheral vein cultures are the gold standard. We aimed to examine the validity of these criteria in patients on HD. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: Adult patients on in-center HD using catheters were prospectively followed from 2011 to 2014 at a large academic-based HD facility (Toronto, Canada). When a CRBSI was suspected, blood culture sets were obtained from four sites (peripheral vein, both catheter hubs, and HD circuit) to determine the guideline-recommended differential time to positivity (DTTP). DTTP criteria were met when catheter hub cultures turned positive ≥120 minutes before peripheral vein cultures. The sensitivity, specificity, and accuracy were first calculated using peripheral vein cultures as the gold standard and then these same calculations were repeated with additional information, including exit site/catheter tip and HD circuit cultures, as the true gold standard. The feasibility of obtaining peripheral vein cultures was determined.
RESULTS: Of 178 suspected CRBSIs, 100 had peripheral vein blood cultures. Using the true gold standard, sensitivity, specificity, and accuracy of blood culture results were highest in samples from the HD circuit (93.5%, 100%, and 95%, respectively). The guideline recommended combination of peripheral vein and arterial hub blood cultures was the least sensitive, specific, and accurate (91.7%, 93.1%, and 92.7%, respectively). The diagnostic criteria using measured DTTP were met in less than one third of events.
CONCLUSIONS: In patients on HD, blood culture results are the most sensitive, specific, and accurate for diagnosing CRBSIs when taken from the HD circuit and the venous catheter hub, and blood culture results are the least sensitive, specific, and accurate in any combination with peripheral vein cultures. The DTTP does not increase diagnostic accuracy, reducing the necessity for venipuncture and its potential vein damage. Future guidelines should consider the applicability of criterion on specific patient populations and tailor them accordingly.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  bacteremia; catheter-related infections; catheterization; catheters, indwelling; humans; indwelling catheters; phlebotomy; renal dialysis; sensitivity and specificity

Mesh:

Year:  2016        PMID: 27037271      PMCID: PMC4858483          DOI: 10.2215/CJN.09110815

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  15 in total

1.  Preventing infections associated with indwelling intravascular access devices.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1997-12

Review 2.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

4.  Initial concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system.

Authors:  Yishai Haimi-Cohen; Ernestine M Vellozzi; Lorry G Rubin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 5.  Metastatic complications of bloodstream infections in hemodialysis patients.

Authors:  Sarah S Lewis; Daniel J Sexton
Journal:  Semin Dial       Date:  2012-12-23       Impact factor: 3.455

Review 6.  Prevention and management of catheter-related infection in hemodialysis patients.

Authors:  Charmaine E Lok; Michele H Mokrzycki
Journal:  Kidney Int       Date:  2010-12-22       Impact factor: 10.612

7.  Phlebotomy teams reduce blood-culture contamination rate and save money.

Authors:  S Surdulescu; D Utamsingh; R Shekar
Journal:  Clin Perform Qual Health Care       Date:  1998 Apr-Jun

Review 8.  Identifying and classifying bloodstream infections among hemodialysis patients.

Authors:  Alexander J Kallen
Journal:  Semin Dial       Date:  2013-04-18       Impact factor: 3.455

9.  Epidemiology and outcome of infective endocarditis in hemodialysis patients.

Authors:  Suraj Maraj; Larry E Jacobs; Shiang-Cheng Kung; Rasib Raja; Prakash Krishnasamy; Rajiv Maraj; Leonard E Braitman; Morris N Kotler
Journal:  Am J Med Sci       Date:  2002-11       Impact factor: 2.378

10.  Treatment guidelines for dialysis catheter-related bacteremia: an update.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2009-07       Impact factor: 8.860

View more
  14 in total

1.  Management of the Hemodialysis Patient with Catheter-Related Bloodstream Infection.

Authors:  Crystal A Farrington; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-05       Impact factor: 8.237

2.  Optimal Approach for the Diagnosis of Hemodialysis Catheter-Related Bacteremia.

Authors:  Tanya S Johns; Michele H Mokrzycki
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 8.237

3.  Management of a Patient with Catheter-Related Bloodstream Infection.

Authors:  Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-05       Impact factor: 8.237

4.  Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism.

Authors:  Crystal A Farrington; Michael Allon
Journal:  Am J Nephrol       Date:  2019-06-26       Impact factor: 3.754

Review 5.  Bacteremia in hemodialysis patients.

Authors:  Masashi Suzuki; Nobuhiko Satoh; Motonobu Nakamura; Shoko Horita; George Seki; Kyoji Moriya
Journal:  World J Nephrol       Date:  2016-11-06

6.  Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Authors:  Stephanie Thompson; Natasha Wiebe; Scott Klarenbach; Rick Pelletier; Brenda R Hemmelgarn; John S Gill; Braden J Manns; Marcello Tonelli
Journal:  BMC Nephrol       Date:  2017-12-08       Impact factor: 2.388

7.  Hemodialysis Tunneled Catheter-Related Infections.

Authors:  Lisa M Miller; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Louise Moist; Matthew Oliver; Jennifer MacRae
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

8.  Recommended Clinical Trial End Points for Dialysis Catheters.

Authors:  Michael Allon; Deborah J Brouwer-Maier; Kenneth Abreo; Kevin M Baskin; Kay Bregel; Deepa H Chand; Andrea M Easom; Leonard Mermel; Michele H Mokrzycki; Priti R Patel; Prabir Roy-Chaudhury; Surendra Shenoy; Rudolph P Valentini; Haimanot Wasse
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

9.  Catheter-Related Bloodstream Infections and Catheter Colonization among Haemodialysis Patients: Prevalence, Risk Factors, and Outcomes.

Authors:  Shamira Shahar; Ruslinda Mustafar; Lydia Kamaruzaman; Petrick Periyasamy; Kiew Bing Pau; Ramliza Ramli
Journal:  Int J Nephrol       Date:  2021-06-19

10.  Fast and furious: a retrospective study of catheter-associated bloodstream infections with internal jugular nontunneled hemodialysis catheters at a tropical center.

Authors:  Varun Agrawal; Anna T Valson; Anjali Mohapatra; Vinoi George David; Suceena Alexander; Shibu Jacob; Yamuna Devi Bakthavatchalam; John Anthony Jude Prakash; Veeraraghavan Balaji; Santosh Varughese
Journal:  Clin Kidney J       Date:  2019-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.